Large-scale testing (Phase 3)WithdrawnNCT02196207What this trial is testingHemophilia Inhibitor Clinical Trials (INHIBIT) PlatformWho this might be right forSevere Hemophilia A Margaret Ragni
Not applicableStudy completedNCT01652027What this trial is testingHemophilia Inhibitor Previously Untreated Patient StudyWho this might be right forHemophilia A The University of Texas Health Science Center, Houston 25
Large-scale testing (Phase 3)Ended earlyNCT04489537What this trial is testingStudy of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or BWho this might be right forHemophilia A With InhibitorHemophilia B With Inhibitor Catalyst Biosciences 18
Post-approval studies (Phase 4)Looking for participantsNCT04647227What this trial is testingSEVENFACT® for Bleeding Events in Hemophilia With InhibitorsWho this might be right forHemophilia A With InhibitorHemophilia B With Inhibitor American Thrombosis and Hemostasis Network 55
Not applicableStudy completedNCT04165135What this trial is testingAn Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care TreatmentWho this might be right forSevere Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHaemophilia A Hoffmann-La Roche 103
Early research (Phase 1)UnknownNCT04768699What this trial is testingStudy of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.Who this might be right forHemophilia A With InhibitorHemophilia B With Inhibitor Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 24
Large-scale testing (Phase 3)Ended earlyNCT06568302What this trial is testingThe Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical TrialWho this might be right forHemophilia aHemophilia BHemophilia a with Inhibitor+1 more ApcinteX Ltd 15
Not applicableUnknownNCT01505946What this trial is testingThrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With InhibitorsWho this might be right forSevere Hemophilia A With Inhibitor Grifols Italia S.p.A 25
Post-approval studies (Phase 4)Looking for participantsNCT06864975What this trial is testingAssessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)Who this might be right forHemophilia a with Inhibitor Runhui WU 110
Not applicableStudy completedNCT03951103What this trial is testingRFVIIIFc (Elocta®) ITI Chart Review in Patients With Haemophilia AWho this might be right forHemophilia A With Inhibitor Swedish Orphan Biovitrum 44
Early research (Phase 1)Study completedNCT04072237What this trial is testingStudy of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With HemophiliaWho this might be right forHemophilia AHemophilia BHemophilia A With Inhibitor+3 more Catalyst Biosciences 11
Not applicableStudy completedNCT04723693What this trial is testingAn Exploration of the Impact of Emicizumab on the Lives of People With Haemophilia and Inhibitors and Their FamiliesWho this might be right forHemophilia A With Inhibitor Haemnet 30
Testing effectiveness (Phase 2)Study completedNCT06010953What this trial is testingSS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand TreatmentWho this might be right forMaleHemophilia A With InhibitorHemophilia B With Inhibitor+1 more Jiangsu Gensciences lnc. 24
Large-scale testing (Phase 3)Ended earlyNCT04303559What this trial is testingThe Hemophilia Inhibitor Prevention TrialWho this might be right forHemophilia A Without Inhibitor Margaret Ragni 1
Testing effectiveness (Phase 2)UnknownNCT04592692What this trial is testingA Pharmacokinetic and Clotting Activity Study of FVIII-PEGLipWho this might be right forHemophilia A With Inhibitor Ascension Healthcare Development Limited 20
Not applicableLooking for participantsNCT05802836What this trial is testingDynamics of the Anti-factor VIII Antibody Signature During Treatment With EmicizumabWho this might be right forSevere Hemophilia ASevere Hemophilia A With InhibitorSevere Hemophilia A Without Inhibitor Christoph Königs 100
Not applicableStudy completedNCT03372993What this trial is testingProspective, Non-interventional Study to Evaluate Immunogenicity of AryoSevenWho this might be right forHemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency+1 more AryoGen Pharmed Co. 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT07158606What this trial is testingUnderstanding Treatment Outcomes and Immunologic Mechanisms in Altuviiio Immune Tolerance InductionWho this might be right forHemophilia A With Inhibitor Versiti Blood Health 15
Large-scale testing (Phase 3)Not Yet RecruitingNCT06938659What this trial is testingLow Dose Emicizumab vs Low Dose Factor VIII in Prophylaxis in Hemophilia A PatientsWho this might be right forHemophilia A Dhaka Medical College 20
Testing effectiveness (Phase 2)Study completedNCT03407651What this trial is testingStudy of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and BWho this might be right forHemophilia A With InhibitorHemophilia B With Inhibitor Catalyst Biosciences 11